Relay Therapeutics to Participate in Two Major Investor Conferences in September
CAMBRIDGE, Mass., Sept. 01, 2026 /CourierPR/ -- Relay Therapeutics, a clinical-stage small molecule precision medicine company, will participate in two major investor conferences in September 2026, providing updates on its drug development pipeline.
On Tuesday, September 8, 2026, the company’s management will take part in a fireside chat at the 2026 Wells Fargo Healthcare Conference. The event is scheduled for 1:30 p.m. Eastern Time. Later, on Wednesday, September 16, Relay Therapeutics will present at the Morgan Stanley 24th Annual Global Healthcare Conference, with the session starting at 9:15 a.m. Eastern Time. Both events will be webcast live and can be accessed through Relay Therapeutics’ website under the News & Events section, at the following link: <https://ir.relaytx.com/news-events/events-presentations>.
The webcasts will be archived and available for up to 30 days following each event, providing a convenient way for investors and interested parties to review the presentations at their convenience.
Relay Therapeutics focuses on developing potentially life-changing therapies for patients with cancer and genetic diseases. The company’s Dynamo® platform integrates advanced computational and experimental approaches to target previously intractable protein pathways. Zovegalisib, the company’s lead clinical asset, is the first pan-mutant selective PI3Kα inhibitor to enter clinical development. Currently, it is in a Phase 3 trial (ReDiscover-2) for HR+/HER2- metastatic breast cancer. Additionally, zovegalisib is being investigated for PI3Kα-driven vascular anomalies, a group of genetic diseases.
Other programs in Relay Therapeutics’ pipeline include treatments for NRAS-driven solid tumors and Fabry disease. The company’s goal is to advance innovative therapies that could significantly impact patient outcomes in oncology and genetic diseases.
For detailed information on the company’s presentations and pipeline, visit Relay Therapeutics’ website at <https://www.relaytx.com>.